Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Operating Expenses | 3,599 | 3,328 | 2,777 | 2,645 | 3,453 |
| Operating Income | -3,599 | -3,328 | -2,777 | -2,645 | -3,453 |
| Other Income | 7 | 4 | 5 | 7 | 3 |
| Pre-tax Income | -3,592 | -3,324 | -2,772 | -2,638 | -3,450 |
| Net Income Continuous | -3,592 | -3,324 | -2,772 | -2,638 | -3,450 |
| Net Income | $-3,592 | $-3,324 | $-2,772 | $-2,638 | $-3,450 |
| EPS Basic Total Ops | -0.14 | -0.13 | -0.13 | -0.06 | -0.17 |
| EPS Basic Continuous Ops | -0.14 | -0.13 | -0.13 | -0.06 | -0.17 |
| EPS Diluted Total Ops | -0.14 | -0.13 | -0.13 | -0.06 | -0.17 |
| EPS Diluted Continuous Ops | -0.14 | -0.13 | -0.13 | -0.06 | -0.17 |
| EBITDA(a) | $-3,594 | $-3,323 | $-2,772 | $-2,618 | $-3,425 |